Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.

Haddad, Fatma; Sawalha, Maryam; Khawaja, Yahya; Najjar, Anas; Karaman, Rafik

Haddad, Fatma; Sawalha, Maryam; Khawaja, Yahya; Najjar, Anas; Karaman, Rafik.

Afiliação

Haddad F; Department of Bioorganic & Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Quds University, Jerusalem P.O. Box 20002, Palestine. iamfromhebron@hotmail.com.
Sawalha M; Department of Bioorganic & Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Quds University, Jerusalem P.O. Box 20002, Palestine. maryam_khaled2@yahoo.com.
Khawaja Y; Department of Bioorganic & Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Quds University, Jerusalem P.O. Box 20002, Palestine. yahya.khawaja@hotmail.com.
Najjar A; Department of Bioorganic & Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Quds University, Jerusalem P.O. Box 20002, Palestine. nash.najjar@gmail.com.
Karaman R; Department of Bioorganic & Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Quds University, Jerusalem P.O. Box 20002, Palestine. dr_karaman@yahoo.com.

Molecules ; 23(1)2017 Dec 25.

Article em En | MEDLINE | ID: mdl-29295587

Assuntos

Dopamina/uso terapêutico; Levodopa/uso terapêutico; Doença de Parkinson/tratamento farmacológico; Pró-Fármacos/uso terapêutico; Animais; Dopamina/química; Portadores de Fármacos/química; Humanos; Levodopa/química

Palavras-chave

Parkinson's disease; blood brain barrier; dopamine; levodopa; prodrug

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Pró-Fármacos / Dopamina / Levodopa Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google